Formidable Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,015
Closed -$498K 332
2022
Q3
$498K Buy
2,015
+44
+2% +$11.9K 0.12% 156
2022
Q2
$491K Buy
1,971
+615
+45% +$166K 0.11% 169
2022
Q1
$449K Sell
1,356
-534
-28% -$164K 0.09% 195
2021
Q4
$679K Buy
1,890
+174
+10% +$58.8K 0.13% 147
2021
Q3
$558K Buy
+1,716
New +$581K 0.1% 184
2019
Q2
Sell
-12,179
Closed -$968K 348
2019
Q1
$968K Buy
+12,179
New +$4.05M 0.38% 64

Other funds holding ABMD

Formidable Asset Management's ABMD Position: Q4 2022 in Review

Formidable Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,015 shares — an estimated $498K sold.

Formidable Asset Management first reported a position in ABMD in Q1 2019 and held it in 6 quarters. The position peaked at $968K in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Formidable Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Formidable Asset Management sold 2,015 Abiomed Inc shares in Q4 2022, an estimated $498K.
  • Formidable Asset Management first reported a position in Abiomed Inc in Q1 2019 and held it in 6 quarters.
  • Formidable Asset Management's Abiomed Inc position peaked at $968K in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Formidable Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.